Publications

Category: Publications 19 May 2021

Author

Patient safety is paramount in drug trials

In a recent article in the New Scientist clinical trials supplement Dr Jorg Taubel, Scientific Lead at Richmond Research Institute, highlights the importance of reducing the risk to patients in phase I clinical trials.

Read more ...

Category: Publications 6 April 2021

Author

Novel rate-controlled fentanyl patch shows promise in phase I clinical trial

Our expertise in ethnic differences and access to over 12,000 first generation Japanese volunteers accelerated our ability to provide robust clinical trial data to support future applications of new chronic pain medicines to the Japanese drug market.

Read more ...

Category: Publications 18 March 2021

Author

A new era for UK-Japanese scientific relations

As the UK and Japan embark on a new trade deal, there are aspirations of greater collaboration and investment between the two nations. Dr Jorg Taubel shares his thoughts on the future needs of the Japanese pharmaceutical market and how UK-Japanese scientific relations can support this in his recent article in the Pharmaceutical Market Europe and PMLive.

Read more ...

Category: Publications 19 January 2021

Author

Siponimod and Cognition in Secondary Progressive Multiple Sclerosis: EXPAND Secondary Analyses.

Co-authored by Christian Wolf

Benedict RHB, Tomic D, Cree BA, Fox R, Giovannoni G, Bar-Or A, Gold R, Vermersch P, Pohlmann H, Wright I, Karlsson G, Dahlke F, Wolf C, Kappos L.

Neurology. 20219; 96:e376-e386. https://doi.org/10.1212/WNL.0000000000011275.

 

Category: Publications 18 November 2020

Author

Siponimod: Disentangling disability and relapses in secondary progressive multiple sclerosis

Co-authored by Christian Wolf

Cree BA, Magnusson B, Rouyrre N, Fox RJ, Giovannoni G, Vermersch P, Bar-Or A, Gold R, Piani Meier D, Karlsson G, Tomic D, Wolf C, Dahlke F, Kappos L.

Multiple Sclerosis Journal 2020; Nov 18:1352458520971819, https://doi.org/10.1177/1352458520971819 (open access).

Category: Publications 16 January 2019

Author

Innovation in Oncology Clinical Trial Design

Co-authored by Hans R. Hendriks

Read more ...

Category: Publications 3 April 2018

Author

The role of pharmacology in anticancer drug development.

Co-authored by Hans R. Hendriks

Read more ...

Category: Publications 25 March 2018

Author

Switching from branded to generic glatiramer acetate: 15-month GATE trial extension results

Co-authored by Christian Wolf

Read more ...

Category: Publications 25 March 2018

Author

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

Co-authored by Christian Wolf

Read more ...

Category: Publications 8 November 2017

Author

Efficacy, pharmacokinetic and pharmacodynamic evaluation of apaziquone in the treatment of non-muscle invasive bladder cancer

Co-published by Hans Hendriks

Read more ...